New Tools Boost Pediatrician Adherence to Peanut Allergy Prevention guidelines

A recent randomized clinical trial led by researchers at Northwestern University and Ann & Robert H. Lurie Children’s Hospital of Chicago demonstrates how innovative clinical tools impact pediatricians’ adherence to peanut allergy prevention guidelines. The study shows that educational videos, electronic health record (EHR) prompts, and tailored parental handouts can considerably improve physician compliance wiht early peanut introduction recommendations, offering a key method to reduce the increasing rate of peanut allergy among American infants.

National guidelines issued in 2017 recommend introducing peanut-containing foods between four to six months of age. Previously, infants were discouraged from early peanut consumption due to concerns about sensitization. However, evidence from prior trials shows that early dietary exposure significantly reduces the prevalence of peanut allergy, which affects over two percent of children nationwide.

Despite these recommendations, pediatrician adherence has been low. Surveys show many clinicians hesitate to advise early peanut introduction during well-child visits, often due to time constraints and a lack of resources. This study addressed this gap by implementing a multifaceted intervention across 30 pediatric practices in Illinois, including federally qualified health centers, private clinics, and academic medical institutions.

The intervention included a clinician training video reinforcing guidelines, real-time EHR prompts to integrate allergy prevention counseling into workflow, and educational handouts for families outlining safe peanut introduction strategies. A visual eczema severity scorecard was also introduced to help identify high-risk infants who may need specialist referral versus those suitable for at-home introduction.

Data from over 18,000 well-child visits at four and six months revealed important results. Practices using the toolkit saw an 84% adherence rate to guidelines among low-risk infants-more than double the 35% rate in control sites. Adherence also improved for high-risk infants, rising to 27% in intervention clinics compared to 10% in controls. High-risk infants in the intervention group were more likely to receive appropriate referrals.